أرسل هذا في رسالة قصيرة: Health-related quality-of-life in a randomized phase III first-line study of gefitinib versus carboplatin/paclitaxel in clinically selected patients from Asia with advanced NSCLC (IPASS)

 __   _     ______     _____     ___     _    _   
| || | ||  /_   _//   / ___//   / _ \\  | \  / || 
| '--' ||   -| ||-    \___ \\  | / \ || |  \/  || 
| .--. ||   _| ||_    /    //  | \_/ || | .  . || 
|_|| |_||  /_____//  /____//    \___//  |_|\/|_|| 
`-`  `-`   `-----`  `-----`     `---`   `-`  `-`